ConductScience.org, home

Paper · 14520460

FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells.

Sturla LM and 2 others. Br J Cancer, 2003. Cited by 20 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells. Papers, record 14520460. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14520460

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FGFR3IIIS: a novel soluble FGFR3 spliced variant that modulates growth is frequently expressed in tumour cells.
PubMed
Journal
Br J Cancer
PubMed
Year
2003
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.33
iCite
Revised in PubMed
2022-03-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sturla LML-M
2Merrick AEA E
3Burchill SAS A

Source PubMed

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alternative SplicingMajor topic
Gene Expression Regulation, NeoplasticMajor topic
NeoplasmsMajor topic
Protein-Tyrosine KinasesMajor topic
Receptors, Fibroblast Growth FactorMajor topic
Blotting, Southern
Cell Division
DNA Primers
Exons
Fibroblast Growth Factor 1
Fibroblast Growth Factor 2
Humans
Immunoglobulins
Oligonucleotides, Antisense
Phosphorylation
Polymerase Chain Reaction
Protein Isoforms
RNA, Messenger
Receptor, Fibroblast Growth Factor, Type 3
Tissue Distribution
Tumor Cells, Cultured

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111,395,371Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors.Am J Pathol2001https://conductscience.org/library/papers/11395371PubMed
210,648,414Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis.Blood2000https://conductscience.org/library/papers/10648414PubMed
311,529,856Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14).Br J Haematol2001https://conductscience.org/library/papers/11529856PubMed
410,098,411RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer.Trends Genet1999https://conductscience.org/library/papers/10098411PubMed
510,433,902Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development.Development1999https://conductscience.org/library/papers/10433902PubMed
610,471,491Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.Nat Genet1999https://conductscience.org/library/papers/10471491PubMed
71,646,484Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.Science1991https://conductscience.org/library/papers/1646484PubMed
89,582,336Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia.J Biol Chem1998https://conductscience.org/library/papers/9582336PubMed
910,594,778Expression and localization of fibroblast growth factors and fibroblast growth factor receptors in the developing rat kidney.Kidney Int1999https://conductscience.org/library/papers/10594778PubMed
1011,906,172Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells.Biochem Biophys Res Commun2002https://conductscience.org/library/papers/11906172PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42,693,342Regulation of PDGF-BB signaling in placental pericytes by soluble PDGFRβ isoforms: implications for fetoplacental vascular development.Angiogenesis2026https://conductscience.org/library/papers/42693342PubMed
41,584,352Unraveling the FGFR-RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose.Acta Pharm Sin B2026https://conductscience.org/library/papers/41584352PubMed
36,794,128High expression of FGFR3 predicts a better prognosis for patients with non-small cell lung cancer in a Chinese population.J Thorac Dis2023https://conductscience.org/library/papers/36794128PubMed
36,107,237Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.Pediatr Surg Int2022https://conductscience.org/library/papers/36107237PubMed
33,804,608Members of the Fibroblast Growth Factor Receptor Superfamily Are Proteolytically Cleaved by Two Differently Activated Metalloproteases.Int J Mol Sci2021https://conductscience.org/library/papers/33804608PubMed
23,696,738Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).PLoS Pathog2013https://conductscience.org/library/papers/23696738PubMed
22,531,302Molecular markers associated with nonepithelial ovarian cancer in formalin-fixed, paraffin-embedded specimens by genome wide expression profiling.Kaohsiung J Med Sci2012https://conductscience.org/library/papers/22531302PubMed
22,203,889Alternative Splicing of Fibroblast Growth Factor Receptor IgIII Loops in Cancer.J Nucleic Acids2012https://conductscience.org/library/papers/22203889PubMed
18,369,415Entropy measures quantify global splicing disorders in cancer.PLoS Comput Biol2008https://conductscience.org/library/papers/18369415PubMed
17,912,529Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target.World J Urol2007https://conductscience.org/library/papers/17912529PubMed

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14520460

GET https://conductscience.org/api/papers/v1/14520460/references?page=2